An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...

The tech giant’s Damo Academy secured a “breakthrough device” designation from the US regulator for its pancreatic cancer-detecting AI model, Damo Panda.

A newly developed radiolabeled antibody that targets the cancer antigen IL13Rα2 has been found to be highly specific, binding ...

OSU scientists created nanoparticles that deliver anti-inflammatory drugs across the blood-brain barrier, offering hope for ...

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive supercomputer will give it the edge to dominate the sector.

Drugs and other treatments can be quite ... Working in a mouse model of triple-negative breast cancer, the researchers used their approach to slow tumor growth far more than treatment with ...

Brain Tumor Organoids Accurately Model Patient Response to CAR T Cell ... identified through a screen for genetic ... Repurposing Drug Shows Promise in Fighting Aggressive Brain Tumors Oct ...

City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting transcription-replication conflicts to combat treatment resistance.

A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ ...

The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.